Sawai Outlook Improves But Japanese Generics Continue To Suffer Under NHI Price Cuts
Prospect Of Regulatory Reform For Japanese Generics Remains Uncertain
Japanese generics giant Sawai appears to be turning a corner, but the impact of National Health Insurance pricing revisions continues to hold the firm – and the rest of the country’s generics industry – back.
